Prosecution Insights
Last updated: October 25, 2026

Cercacor Laboratories Inc.

Technology areas: Chemistry & Materials • Semiconductors, Circuits & Optics • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering

4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Cercacor Laboratories Inc. is currently navigating 4 pending office actions within the Medical Devices & Mechanical Engineering technology area. These matters are distributed across 4 distinct examiners, ensuring that each individual application is subject to an independent review process. This lack of examiner overlap means that the company must engage with different sets of examination criteria and feedback styles. For the legal team, this necessitates a customized approach for each case rather than a centralized negotiation strategy.

The portfolio's activity is spread across 4 distinct art units, reflecting a range of technical subject matter within the medical device field. This distribution can lead to varying timelines and procedural expectations. MORONESO, JONATHAN DREW is noted as the busiest examiner for the portfolio, currently overseeing 1 pending office action. Because this busiest examiner only handles a single case, the workload is spread among the assigned officials.

The presence of multiple examiners and art units suggests that the firm is dealing with a broad array of intellectual property challenges. Practitioners should be prepared to maintain consistency in technical arguments across these different venues to avoid conflicting statements. With MORONESO, JONATHAN DREW managing 1 pending office action, the remaining files are each under the jurisdiction of other examiners, requiring a broad allocation of resources to manage the active workload effectively.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
2
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (75%)
1
Medium (25%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (25%)
§101 + other1 (25%)
§103 only1 (25%)
Multi-statute (no §101)1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
25% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
25% of docket
2
Mechanical / Eng
50% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MORONESO, JONATHAN DREW 1 53.1% +34.8%
SUN, CAITLYN MINGYUN 1 63.7% +11.8%
PLUMB, NIGEL H 1 90.7% +1.1%
SEREBOFF, NEAL 1 28.3% +33.4%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18494585 NON-INVASIVE MEDICAL MONITORING DEVICE FOR BLOOD ANALYTE MEASUREMENTS MORONESO, JONATHAN DREW 52d overdue
17817602 SYSTEMS AND METHODS FOR KINK DETECTION IN A CANNULA PLUMB, NIGEL H 62d
17727608 OPTICAL SENSING SYSTEMS AND METHODS FOR DETECTING A PHYSIOLOGICAL CONDITION OF A PATIENT SEREBOFF, NEAL —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18494585 NON-INVASIVE MEDICAL MONITORING DEVICE FOR BLOOD ANALYTE MEASUREMENTS MORONESO, JONATHAN DREW 52d overdue
18352850 ELECTROCHEMICAL GLUCOSE SENSING BY EQUILIBRIUM GLUCOSE BINDING TO GENETICALLY ENGINEERED GLUCOSE BINDING PROTEINS SUN, CAITLYN MINGYUN 68d
17727608 OPTICAL SENSING SYSTEMS AND METHODS FOR DETECTING A PHYSIOLOGICAL CONDITION OF A PATIENT SEREBOFF, NEAL —

Top Art Units

Art UnitApps
3791 1
1795 1
2855 1
3683 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18494585 NON-INVASIVE MEDICAL MONITORING DEVICE FOR BLOOD ANALYTE MEASUREMENTS MORONESO, JONATHAN DREW 3791 §101§103§112 Final Rejection 52d overdue Pending Oct 25, 2023
18352850 ELECTROCHEMICAL GLUCOSE SENSING BY EQUILIBRIUM GLUCOSE BINDING TO GENETICALLY ENGINEERED GLUCOSE BINDING PROTEINS SUN, CAITLYN MINGYUN 1795 §103 Non-Final OA 68d Pending Jul 14, 2023
17817602 SYSTEMS AND METHODS FOR KINK DETECTION IN A CANNULA PLUMB, NIGEL H 2855 §102§103§112 Final Rejection 62d Pending Aug 04, 2022
17727608 OPTICAL SENSING SYSTEMS AND METHODS FOR DETECTING A PHYSIOLOGICAL CONDITION OF A PATIENT SEREBOFF, NEAL 3683 §101 Non-Final OA — Pending Apr 22, 2022

Managing Cercacor Laboratories Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Cercacor Laboratories Inc. have?

Cercacor Laboratories Inc. has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.

Which USPTO examiner handles the most Cercacor Laboratories Inc. applications?

Jonathan Drew Moroneso has the most, with 1 of Cercacor Laboratories Inc.'s pending office actions.

What technology area are Cercacor Laboratories Inc.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month